The effect of dilazep (1, 4-bis L3-(3, 4, 5-trimethoxy benzoyloxy) -propyl] perhydro-1, 4-diazepine) on the aortic intimal thikening was examined. New Zealand white rabbits were used. The intimal injury was induced by insertion of polyethylene tubing which was drawn out on the next day. Dilazep was intramuscularly administerd in a dose of 50 mg/kg three times a day. In Experiment I, rabbits were sacrificed immediately after the drawing out of tubing. In Experiment II, each animal of the experimental and control groups which were composed of ten animals respectively were sacrificed 10 days after the drawing out of tubing. Five sections from the thoracic aorta were embedded in Epon and the thickness of the thrombi in Experiment I and of the intima in Experiment II was measured.
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In Experiment I, the thickness of the thrombi in the dilazep group was smaller than that in the control group (p<0.05).
In Experiment II, the average thickness of the intima in the dilazep group was smaller than that in the control group (p<0.2), but the difference was not statistically significant as that of Experiment I. Thus it was considered that the degree of intimal thickening after mechanical injury might not be proportional only to the amount of aggregated platelets and platelet derived growth factor.
